ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Selling, General & Administrative
ADC Therapeutics SA
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Selling, General & Administrative
$-105.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Selling, General & Administrative
CHf-10.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Selling, General & Administrative
$-206.4m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Selling, General & Administrative
CHf-33.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
Idorsia Ltd
SIX:IDIA
|
Selling, General & Administrative
CHf-504m
|
CAGR 3-Years
-100%
|
CAGR 5-Years
-75%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Selling, General & Administrative
CHf-27.5m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Selling, General & Administrative?
Selling, General & Administrative
-105.9m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Selling, General & Administrative amounts to -105.9m USD.
What is ADC Therapeutics SA's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-65%
Over the last year, the Selling, General & Administrative growth was 25%. The average annual Selling, General & Administrative growth rates for ADC Therapeutics SA have been -4% over the past three years , -65% over the past five years .